Medical Home Development Group   Report issue

Academic/Hospital
Founded: Washington D.C. United States (2011)

Organization Overview

First Clinical Trial
2018
NCT03861832
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Medical Home Development Group

Active Ingredients

Drugs in Other Trials (1)

kb220 (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1